Table 4.
Effects of non-surgical interventions on DGE following pancreatectomy
| Author | Type of study | No. of patients | Type of intervention | Results |
|---|---|---|---|---|
| Yeo et al. (1993) [106] | Prospective, randomized, placebo-controlled trial | 118 • 58 • 60 |
IV erythromycin 6-hourly from third to tenth postoperative days vs. equal volume of 0.9 % saline | • 37 % reduction in incidence of DGE in the intervention group |
| Kollmar et al. (2008) [114] | Prospective, randomized, double-blinded placebo-controlled trial | 67 • 35 • 32 |
Prophylactic octreotide | • No effect on gastric emptying and incidence of POPF |
| Ohwada et al. (2001) [82] | Prospective randomized controlled trial | 31 • 14 • 17 |
Low-dose erythromycin 8 hourly from POD 1 to 14 vs. H-2 receptor antagonists and gastrokinetic drugs after Billroth-I pylorus-preserving PD | • 75 % reduction in incidence of DGE in the intervention group • Decreased duration of nasogastric drainage • Early resumption of oral intake |
| Shan et al. (2005) [115] | Prospective randomized controlled trial | 23 • 11 • 12 |
Somatostatin prophylaxis | • Incidence of DGE 82 % in intervention group vs. 25 % in the control group (p < 0.01) • Somatostatin increased the half time of solid phase emptying • Somatostatin reduced fasting plasma motilin levels and caused prolonged suppression of plasma motilin as compared to the control group |